Risk factor
Very high price volatility
Profitability factor
Greatly overvalued vs peers
About
Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for...
Company Valuation
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.
Target Price
The average target price of SGHT is 9.7 and suggests 65% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas
Buy
Sell